Impact of glycemic control on treatment efficacy and safety during nabpaclitaxel plus gemcitabine therapy in unresectable pancreatic cancer.

Authors

null

Junko Tauchi

Department of Pharmacy, National Cancer Center Hospital East, Kashiwa City, Japan

Junko Tauchi , Akira Shinohara , Ken Ohashi , Taro Shibuki , Gen Kimura , Kumiko Umemoto , Kazuo Watanabe , Mitsuhito Sasaki , Hideaki Takahashi , Yusuke Hashimoto , Hiroshi Imaoka , Izumi Ohno , Shuichi Mitsunaga , Masafumi Ikeda , Toshikatsu Kawasaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 337)

DOI

10.1200/JCO.2019.37.4_suppl.337

Abstract #

337

Poster Bd #

H15

Abstract Disclosures

Similar Posters